Popular on eTradeWire


Similar on eTradeWire

Device innovations, connected delivery and regulatory guidance for advanced parenteral systems

eTradeWire News/10664002
The global pre-filled syringes market was valued at $1139.6 million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027.

BOSTON - eTradeWire -- With all the above in mind, the 9th annual Pre-Filled Syringes East Coast conference will bring together leading industry experts representing big pharma and device developers to discuss the key drivers accelerating the expansion of the industry.

The past year has seen significant developments in the injectables landscape with the rapid introduction and development of vaccines in response to the pandemic, updates in regulations including the EU MDR and FDA guidance on bridging studies, and increasing industry acceptance of connectivity to aid the user experience. As part of SMi's leading injectable series, the 2022 conference will provide an exclusive insight into the latest developing technologies for device design, advances in parenteral device platforms and development, insights into growing integration of digital health and deep dives into recent case studies on novel delivery systems.

More on eTradeWire News
This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more.

Visit the website at: www.pfsamericas.com/

Chair for 2022:

Gretchen Vandal, Sr. Director, Head of Global Regulatory Affairs – Devices and Combination Products, Takeda

Guest FDA Speaker:
  • John Barr Weiner, Associate Director for Policy and Product Classification Office, Office of Combination Products FDA

Featured 2022 Speakers Include:
  • Joyce Zhao, Associate Director, Combination Product, Takeda
  • Suzette Roan, Associate VP and Head of Global Device Regulatory Affairs, Sanofi US
  • Christine lynn lanning, Distinguished Scientist, Device Area Leader, Merck
  • Heather l. Guerin, Associate Director, Regulatory Affairs – CMC, Janssen
  • Tieming Ruan, Senior Director of Device Development, Alexion Pharmaceuticals
  • John Schalago, Executive Director, Senior Global Program Director Regulatory Affairs, Novartis
  • Gretchen Piwinski, Manager, Combination Product Laboratories, Regeneron
  • Michael Song, Associate Director, Takeda
  • Deep S Bhattacharya, Senior Scientist, Drug Product Development and Design, Pfizer

BENEFITS OF ATTENDING:
  • Explore the latest developments in innovative technologies for device design accelerating the path to self-administration
  • Assess the evolving regulatory landscape for pre-filled syringes and discuss approaches to work with regulators as guidance is updated
  • Engage in panel discussions with industry leaders to navigate the accelerating digital health landscape for combination products and drug delivery systems
  • Understand the landscape of delivery for novel drug products and key considerations to overcome challenges in CCI

View the full agenda and speaker line-up online: www.pfsamericas.com/

More on eTradeWire News
Who should Attend:
  • Drug-delivery developers
  • Medical Device Engineers
  • Primary Packaging material designers
  • Secondary packagers
  • Smart device developers
  • Training device developers
  • Device-safety solution providers
  • Drug developers


Contact
Richard Jones
SMi Group
***@smi-online.co.uk


Source: SMi Group
Filed Under: Medical

Show All News | Report Violation

0 Comments